Navigation Links
Cytos Biotechnology Ltd Announces the Completion of Patient Enrolment in the On-going Phase 2b Study of CYT003 for the Treatment of Allergic Asthma
Date:10/20/2013

ZURICH, October 21, 2013 /PRNewswire/ --

Cytos Biotechnology Ltd (SIX:CYTN) ("Cytos" or the "Company") today announced that patient enrolment has been completed in the on-going phase 2b study with its lead product CYT003. This study investigates the effectiveness, safety and tolerability of CYT003 in patients with moderate to severe allergic asthma not controlled on their standard treatment.

Based on the completion of the enrolment of this study, Cytos will call the second tranche of the convertible loan notes in the amount of CHF 6.625 million from Abingworth, venBio, Aisling and Amgen, which was part of the investment by this syndicate of investors in May 2012.

Dr. Christian Itin, Chairman and CEO of Cytos, said: "We are pleased with the progress of our Phase 2b study in patients with moderate to severe allergic asthma. The study is on track and we expect topline data from the study to be available in the second quarter of 2014."

About Cytos Biotechnology Ltd

Cytos is a public biopharmaceutical company focused on the development of targeted immuno-therapies. The Company's lead product candidate CYT003 is a novel, first-in-class, immune modulator in Phase 2 clinical development as a potential new treatment for asthma. CYT003 has a novel mechanism of action that inhibits the immune response that causes asthma, and may therefore be beneficial for the control of asthma. In a successfully completed Phase 2a study, CYT003 was shown to maintain asthma control and lung function in patients with persistent allergic asthma despite withdrawal of standard therapy with inhaled corticosteroids. CYT003 has been shown to have a good safety and tolerability profile in more than 450 individuals receiving the active agent so far.

Cytos was founded in 1995 as a spinoff from the Swiss Federal Institute of Technology (ETH) in Zurich. It is located in Schlieren (
'/>"/>

SOURCE Cytos Biotechnology Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cytos Biotechnology Ltd Reports Second Quarter 2013 Financial Results and Recent Developments
2. Cytos Invites to the Annual Shareholders Meeting 2013
3. A*STAR and Cytos Bring Singapores First Influenza Vaccine to Clinical Testing
4. Cytos VLP Platform is Basis for Phase 1 Clinical Trial with Anti-IgE Vaccine
5. CytoSorbents Receives Approximately $400,000 in Non-Dilutive Capital from the Sale of Net Operating Loss Carryovers
6. Cytos Biotechnology Ltd Reports Third Quarter 2012 Financial Results, Recent Development and Outlook
7. NextSource Biotechnology Launches New Strategic Approach to Mitigate Slow-Downs in Manufacturing of Matured Medications in High Demand
8. Goodwin Biotechnology Announces the Appointment of SooYoung S. Lee, PhD as Chief Operating Officer
9. Jeannette R. Jakus, MD, MBA, Awarded American Academy of Dermatology Translational Biotechnology Fellowship
10. TWi Biotechnology Receives Patent Allowance for Its Lead Drug Candidate AC-201 in the United States
11. The Galien Foundation Announces 2013 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) ... Consumables Market - Global Industry Analysis, Size, Share, ... report to their offering. (Logo: ... consumables are products which are used on patients ... restoration and in treatment of associated gingival tissues. ...
(Date:1/15/2014)... 2014 AARP Foundation today announced it has ... adults suffering from the severe cold weather that has ... are committed to helping those in need; so to ... will match dollar-for-dollar contributions up to $250,000, which could ... will be administered through AARP Foundation. ...
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: ... commitments from institutional investors to purchase an aggregate ... stock in an at-the-market registered direct offering, led ... The Company entered into definitive purchase agreements with ... to sell an aggregate of 3,603,603 shares of ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3
... 16, 2010 Cylene Pharmaceuticals, Inc. will present advances ... at the 22nd EORTC-NCI-AACR symposium on Molecular Targets and ... Berlin, Germany. CX-4945 is the first and only CK2 ... exciting new approach for the treatment for many different ...
... 2010 Reportlinker.com announces that a new market ... Global Antibiotics Industry ... This report analyzes the worldwide markets for Antibiotics ... Penicillin, Cephalosporins, Macrolides, Quinolones, Carbapenems, and Other Antibiotics ...
Cached Medicine Technology:Cylene to Present Advances with Industry's Only Clinical CK2 Inhibitor, CX-4945, at EORTC-NCI-AACR 2Cylene to Present Advances with Industry's Only Clinical CK2 Inhibitor, CX-4945, at EORTC-NCI-AACR 3Reportlinker Adds Global Antibiotics Industry 2Reportlinker Adds Global Antibiotics Industry 3Reportlinker Adds Global Antibiotics Industry 4Reportlinker Adds Global Antibiotics Industry 5Reportlinker Adds Global Antibiotics Industry 6Reportlinker Adds Global Antibiotics Industry 7Reportlinker Adds Global Antibiotics Industry 8Reportlinker Adds Global Antibiotics Industry 9Reportlinker Adds Global Antibiotics Industry 10Reportlinker Adds Global Antibiotics Industry 11Reportlinker Adds Global Antibiotics Industry 12Reportlinker Adds Global Antibiotics Industry 13Reportlinker Adds Global Antibiotics Industry 14Reportlinker Adds Global Antibiotics Industry 15Reportlinker Adds Global Antibiotics Industry 16Reportlinker Adds Global Antibiotics Industry 17Reportlinker Adds Global Antibiotics Industry 18Reportlinker Adds Global Antibiotics Industry 19
(Date:4/16/2014)... fertility treatments are the leading cause of increases ... elevated risk of premature birth, these results are ... Fertility and Sterility . The article identifies ... reduce the odds of multiple births and prematurity, ... (IVF) and improving doctor-patient communications about the risks ...
(Date:4/15/2014)... Handling frozen fish caused nearly half of all injuries ... injuries on freezer-longliner vessels operating off the coast of ... Many of those injuries and others aboard the two ... interventions, and the research methods used in the study ... other types of commercial fishing, said researcher Devin Lucas. ...
(Date:4/15/2014)... Group published in the European Journal of Cancer ... categorization of tumor response or various aspects of progression ... database. They found that modeling target lesion tumor ... above and beyond that of the other components of ... United States National Cancer Institute, and the National Cancer ...
(Date:4/14/2014)... chemotherapy over the past decade, but targeting drugs to ... a major challenge. , Nanotechnology has unlocked new ... nanocarriers, or capsules, that can transport cargoes of small-molecule ... catch? These carriers are tiny, and it matters just ... nanometers to 100 nanometers, and the drugs can end ...
(Date:4/14/2014)... at Henry Ford Hospital reached a medical milestone ... replacement using a novel way to access the ... in the United States performing the unique procedure ... by temporarily connecting major blood vessels. , Northern ... first transcaval procedure on July 3, 2013 when ...
Breaking Medicine News(10 mins):Health News:Preterm births, multiples, and fertility treatment 2Health News:Preterm births, multiples, and fertility treatment 3Health News:Changes in processing, handling could reduce commercial fishing injuries 2Health News:Can refined categorization improve prediction of patient survival in RECIST 1.1? 2Health News:Nano shake-up 2Health News:Henry Ford Hospital hits new heart valve surgery milestone 2
... Van Andel Research Institute (VARI) investigators working ... two types of kidney tumors previously thought to be ... This finding will help doctors to more accurately diagnose ... using molecular data to diagnose cancer in general. , ...
... May 9 is National VA Research Week, themed ... of VA investigators and,collaborators, as well as the ... VA research studies. With state-of-the-art electronic,records and close ... to,conduct crucial research. Because most of its researchers ...
... adolescents can have a long-term positive impact on sexual ... a new RAND Corporation study. , Researchers found that ... drug abuse prevention program as adolescents were less likely ... years later, according to the findings published online by ...
... New Screening Test Will Focus on 4.3 Million Annual ... Group Inc. (OTC Bulletin Board: BMSN) and Entest BioMedical ... has been signed with Dr. Brian Koos, a professor ... of Medicine at UCLA for the development, ...
... conferenceEPHRATA, Pa., April 29 Did you know ... breast cancer in Pennsylvania who are uninsured or underinsured? ... not aware of the program or how it can benefit ... Coalition (PBCC), in partnership with Senator Vince Hughes, is publicizing ...
... Mass., April 29 Waters ... the United States Drug Enforcement Administration (U.S. DEA) purchased ... of training new forensic chemists at the Special Testing ... important resource in assisting local, state and federal law ...
Cached Medicine News:Health News:Finding will improve accuracy of cancer diagnosis 2Health News:MultiVu Video Feed: VA Research Week Offers Glimpse into Medicine's Future 2Health News:Teen drug education also helps curb risky sexual behavior, study finds 2Health News:Bio-Matrix Scientific Group and Entest BioMedical Sign Contract With UCLA Researcher to Develop Gestational Diabetes Screening Test 2Health News:Free Treatment for Breast Cancer Available in Pennsylvania 2Health News:Waters Corporation Announces U.S. Drug Enforcement Administration Acquires Waters ACQUITY UPLC System to Train Forensic Chemists in Drug Screening and Profiling 2
The UltraLite Post Op Brace provides a fixed or range of motion control. The UltraLite Post Op Brace indications include: , Post knee trauma , Peri-operative use , Conservative management of isolated...
... was designed to meet the constant demands ... kit provides all components necessary to fit ... 1002-A4 Aluminum pre-contoured adjustable knee joints , ... 2 Unique adjustable thigh bands , Ortho-wick™ ...
... This lightweight orthosis is designed ... basilar joint while allowing unobstructed motion ... a more custom fit the splint ... and formed using a heat gun. ...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
Medicine Products: